GFAP and major depressive disorder: While astrocytes can be detected by various markers, such as GFAP, vimentin, AlDh1L1, and S100-β, GFAP was considered to be an appropriate marker for this study, as most studies on the changes in astrocytes in postmortem MDD patients have used GFAP [40].